No Data
No Data
HKEX In Focus: Peijia Medical-B (09996) resumed trading with a rise of over 5%. The 2023 annual performance has been audited and the year-on-year loss narrowed by 3.7%.
After the resumption of trading this morning, Peijia Medical-B (09996) rose and as of press time, increased by 5.74%, to HKD 3.87, with a turnover of HKD 5.87 million.
The 2023 annual performance of Peijia Medical - B (09996) is the same as the unaudited annual performance disclosed. Resumption of trading on June 17th.
Peijia Medical -B (09996) announced that the company's shares will resume trading at 9:00 am on June 17, 2024.
PEIJIA Medical -B (09996.HK) resumed trading this morning.
Peijia Medical -B (09996.HK) announced on June 17th that its shares will resume trading at 9:00 am today (6/17/2024).
Peijia Medical-B (09996): Resumes trading on June 17.
Paijia Medical -B (09996) announced that its 2023 annual performance has been audited and verified in accordance with the International Auditing and Assurance Standards Board ...
PEIJIA-B: (1) AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023; AND (2) RESUMPTION OF TRADING
Peijia Medical (09996.HK) will hold a board of directors meeting on June 15 to approve the annual performance.
On June 14, Gelonhui announced that Peijia Medical (09996.HK) will hold another board of directors meeting on June 15, 2024 to consider and approve the audited annual performance of the group for the year ending December 31, 2023, and to consider proposing the distribution of final dividends (if any).
No Data